论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
miR-522-3p 通过调节葡萄糖摄取和 GLUT1 表达来促进骨肉瘤细胞生长
Authors Chen R, Lin J, Yan W, Chen D
Received 27 May 2019
Accepted for publication 24 September 2019
Published 1 November 2019 Volume 2019:12 Pages 9053—9058
DOI https://doi.org/10.2147/OTT.S217324
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Jyoti Bajaj
Peer reviewer comments 2
Editor who approved publication: Dr Takuya Aoki
Purpose: In a recent study, Kang et al reported a novel miRNA named miR-522-3p with critical roles in phagocytosis, in which GLUT1 played a critical role, indicating the possible interactions between them. This study aimed to investigate the role of miR-522-3p in osteosarcoma (OS).
Methods: Gene expression was analyzed by qPCR and Western blot. Overexpression experiments were performed to analyze gene interactions. Glucose uptake assay was performed to analyze the effects of glucose uptake in cells. CCK-8 assay was used to analyze cell proliferation.
Results: We found that miR-522-3p and GLUT1 were both upregulated in OS and positively correlated. Follow-up showed that high levels of miR-522-3p expression predicted poor survival. In OS cells, miR-522-3p overexpression led to upregulated GLUT1 expression and increase glucose uptake. Analysis of cell proliferation assay showed that overexpression of miR-522-3p and GLUT1 led to increased cell proliferate rates. In addition, GLUT1 siRNA silencing resulted in reduced effects of miR-522-3p overexpression.
Conclusion: MiR-522-3p promotes OS cell growth through reprogramming glucose metabolism.
Keywords: miR-522-3p, osteosarcoma, GLUT1, survival
